Date: Thursday, October 10, 2019
Time: 13:00-17:30
Venue: Novotel London West, London, UK
Fee: 49 GBP ISOPP 2019 Registrants
        149 GBP Non ISOPP 2019 Registrants. Pre registration is required.

Note: The Workshop runs concurrently with the Introduction to Oncology Pharmacy Course. Participation is only possible in one or the other.

Workshop Description:
This interactive Workshop will focus on the education needs of ISOPP / BOPA members, as identified in ISOPP’s recent needs assessment surveys  around the use of Biosimilars, as well as the feedback collected regarding: the uptake of Biosimilars around the world, how the implementation has been managed, and what challenges are faced by pharmacists working on the implementation of Biosimilars.

Program at a Glance:
13:00     Welcome and introduction
13:15     Session 1: Biosimilars – How are they developed and tested? (Sponsored by Accord)
14:00     Session 2: Case Studies - Comparing experiences of implementing Biosimilars around the world
14:45     Session 3: The challenges of bringing Biosimilars to market (Sponsored by Pfizer)
15:30     Afternoon tea
16:00     Session 4: Administration and patient safety
16:45     Session 5: Panel Discussion
17:30     End of workshop

Presenter Information: 

Paresh Patel, Senior Biosimilar Business Development Manager, Accord, UK

Simon Cheesman, Lead Haematology Pharmacist at UCLH, UK

Jatinder Harchowal, Chief Pharmacist and Clinical Director, Royal Marsden Hospital, UK

Glenn Myers, Clinical Pharmacist, The Moncton Hospital, Moncton, Canada

Winnie Wanjiku Mwangi, Oncology and Clinical Pharmacist, Meru Teaching and Referral Hospital, Kenya

Enrico Bovi, Pfizer, Tadworth, UK

Geoff Saunders, Consultant Pharmacist, The Christie Hospital UK, UK

Registration: Register now! Space is limited and pre-registration is required. 

If you have already registered for ISOPP 2019 and wish to register for this Workshop after the fact, please email register@isopp.org.